SolasCure

Series-B
solascure.com Biotech & Healthcare Cambridge, United Kingdom
Total Funding $34M
Latest Round Undisclosed Series-B
Last Announced Apr 26, 2023
Investors 9 Backers
Decision Makers 6 Available

About SolasCure

Transforming chronic wound care with breakthrough enzymatic technology

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B
Global Headquarters Cambridge, United Kingdom
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website solascure.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile @solascure (62 followers)
LinkedIn Corporate Company Profile

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised undisclosed · Series-B

    fundraisingfox.com

  2. Capital Raise

    Raised $13,000,000 · Series-B

    startupintros.com

  3. Capital Raise

    Raised $21,000,000 · Series-A

    startupintros.com

Investors & Backers

9
BRAIN Biotech AG
Development Bank of Wales
European Innovation Council Fund
Eva Pharma
François Fournier
Innovate UK
Jonathan Milner
Seneca Partners
Wealth Club

Funding History

3 Rounds
Series-B equity · Apr 26, 2023
Series-B equity · Mar 1, 2023
Series-A equity · Aug 1, 2021

Founders & Leadership

6

Bela Kelety

Chief Technology Officer

Work email & phone locked Unlock →

Benjamin Newmark

Founder

Work email & phone locked Unlock →

David Fairlamb

Chief Development Officer

Work email & phone locked Unlock →

Lee Harle

Chief Executive Officer

Work email & phone locked Unlock →

Oliver Schofield

Chief Financial Officer

Work email & phone locked Unlock →

Sam Bakri

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts